Home › NDC Lookup › Ingredients › Ammonium Chloride, Matricaria Recutita,C... › 62795-1007-03
BHI Back AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, and TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1; 10 [hp_X]/1; 5 [hp_X]/1; 6 [hp_X]/1; 5 [hp_X]/1; 8 [hp_X]/1 Tablet, 100-count — NDC 62795-1007-03 package photo

BHI Back AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, and TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1; 10 [hp_X]/1; 5 [hp_X]/1; 6 [hp_X]/1; 5 [hp_X]/1; 8 [hp_X]/1 Tablet, 100-count

by MediNatura Inc · 1 BOTTLE in 1 CARTON (62795-1007-3) / 100 TABLET in 1 BOTTLE
NDC 62795-1007-03
🏷️ FDA NDC (as labeled) 62795-1007-3 billing pads the package segment with a zero
This package
Contains100-count Pack sizes2 compare ↓
Also comes in: 100 tablets 62795-1007-02
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 62795-1007-3
Product NDC 62795-1007
11-digit billing NDC 62795100703
NCPDP billing unit EA — each (per item)
UNII 01Q9PC255D, G0R4UBI2ZZ, 23H32AOH17, 639KR60Q1Q, 36XQ854NWW, 6IO182RP7A
SPL Set ID aa622a5b-16de-4098-9c3f-d7569f7d2c2f
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-08-30
Route ORAL
Dosage form TABLET
Substance AMMONIUM CHLORIDE; MATRICARIA RECUTITA; CITRULLUS COLOCYNTHIS FRUIT PULP; GELSEMIUM SEMPERVIRENS ROOT; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF
GPI-14 99870010000300
GPI class BHI Back Pain Relief
Why two NDCs? The FDA registers this code as 62795-1007-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 62795-1007-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerMediNatura Inc
Labeler code62795
First marketedAug 2014
Product typeHuman Otc Drug
Portfolio33 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

BHI Back is a homeopathic tablet taken by mouth containing ammonium chloride, matricaria recutita (chamomile), citrullus colocynthis fruit pulp, pseudognaphalium obtusifolium, toxicodendron pubescens leaf, and gelsemium sempervirens root. In homeopathic practice, these ingredients are traditionally used to address back discomfort. Homeopathic products are marketed based on homeopathic tradition and have not been evaluated by the FDA for effectiveness.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
ShapeRound
ImprintLeafman
Size9 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII J2B2A4N98G
    Lactose is a natural sugar derived from milk. In medications, it serves as a filler and binder to add bulk and help hold tablet or capsule ingredients together during manufacturing.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive Ingredients: **Dextrose, ** Lactose, Magnesium Stearate, **Maltodextrin **contains one or more of these ingredients.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 100 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
BHI Back 6 [hp_X]/1; 10 [hp_X]/1; 5 [hp_X]/1; 6 [hp_X]/1; 5 [hp_X]/1; 8 [hp_X]this 62795-1007-03 MediNatura 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2014
On the market since
Aug 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
62795-1007-03 You're viewing this 1 BOTTLE in 1 CARTON (62795-1007-3) / 100 TABLET in 1 BOTTLE 2014-08-30 Active
62795-1007-02 100 TABLET in 1 BOTTLE (62795-1007-2) 2023-05-23 Active

Pack size FAQ

What quantity is in NDC 62795-1007-03?
NDC 62795-1007-03 is a 100-count package — 1 bottle in 1 carton / 100 tablet in 1 bottle.
What is the difference between NDC 62795-1007-03 and NDC 62795-1007-02?
Both are BHI Back AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, and TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1; 10 [hp_X]/1; 5 [hp_X]/1; 6 [hp_X]/1; 5 [hp_X]/1; 8 [hp_X]/1 Tablet — the drug itself is identical. NDC 62795-1007-03 is the 100-count package, while NDC 62795-1007-02 is the 100 tablets package.
What NDC number is used to bill for this package of BHI Back AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, and TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1; 10 [hp_X]/1; 5 [hp_X]/1; 6 [hp_X]/1; 5 [hp_X]/1; 8 [hp_X]/1 Tablet?
Bill NDC 62795-1007-03 — the 11-digit billing format is 62795100703. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

BHI Back AMMONIUM CHLORIDE, MATRICARIA RECUTITA,CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, and TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1; 10 [hp_X]/1; 5 [hp_X]/1; 6 [hp_X]/1; 5 [hp_X]/1; 8 [hp_X]/1 TABLET is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 62795-1007-3, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 62795-1007-03, written without dashes as 62795100703. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 62795-1007-03, the first segment (62795) is the labeler code FDA assigned to MediNatura Inc; the middle segment (1007) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (03) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by MediNatura Inc. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 100 tablets (62795-1007-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
MediNatura Inc is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 15 words ▾

USES For the temporary relief of minor back pain, leg & hip pain, muscle spasm

⏱️ Dosage and Administration 71 words ▾

DIRECTIONS At first sign of symptoms: Adults and children 12 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Standard dosage: Adults and children 12 years and older: take 1-2 tablets 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 12, consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow.

⚠️ Warnings 45 words ▾

WARNINGS Warnings: If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Back or any of its ingredients exists.

🧪 Active Ingredient 26 words ▾

ACTIVE INGREDIENT Each tablet contains: Ammonium muriaticum 6X, *Chamomilla 10X, *Colocynthis 5X, *Gelsemium sempervirens 6X, *Gnaphalium polycephalum 5X, *Rhus toxicodendron 8X 50 mg each. *Natural Ingredients

🧪 Inactive Ingredients 17 words ▾

INACTIVE INGREDIENT Inactive Ingredients: **Dextrose, ** Lactose, Magnesium Stearate, **Maltodextrin **contains one or more of these ingredients.

🎯 Purpose 17 words ▾

PURPOSE Back Pain Relief Tablets Relieves: • Back Pain • Leg & Hip Pain • Muscle Spasm

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 62795-1006-02 · MediNatura 62795-1008-03 · MediNatura →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.